secwatch.observer — SEC 8-K summary
======================================

Issuer:     ImageneBio, Inc. (IMA)
CIK:        0001835579
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001193125-25-173626
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ImageneBio dismisses EY, appoints PwC as auditor effective Aug 2, 2025
----------------------------------------------------------------------

- Audit committee dismissed Ernst & Young LLP as independent auditor effective August 2, 2025.
- No disagreements or reportable events occurred during EY's audit periods (2024, 2023 and interim).
- PricewaterhouseCoopers LLP appointed as new auditor for fiscal year ending Dec 31, 2025.
- PwC previously served as auditor of Inmagene Biopharmaceuticals prior to merger with ImageneBio.
- EY's audit reports for 2024 and 2023 were unqualified, with no adverse opinions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525173626/0001193125-25-173626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835579/000119312525173626/d88091d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-173626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer